Holiday Sale | Save 50%
SubscribeLogin
Holiday Sale | Save 50%
Published

Sweden’s Acorai bags €4.2M to advance heart failure management devices

Summary by Silicon Canals
Helsingborg-based Acorai, a Swedish company specialising in heart failure management devices, announced that it secured $4.5M (approximately €4.28M) in a fresh round of funding.  The investment, made by the European Innovation Council (EIC) Fund, Taiwan Medical University, and private investors, will support the completion of clinical studies and regulatory approvals in the US and Europe. Earlier this year, in January 2024, Acorai closed an over…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

HelsingborgHelsingborg
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal